Want to see HK:0673 full AI Analyst Report?
0673 Stock Chart & Stats
HK$0.76
HK$0.03(9.09%)
At close: 4:00 PM EST
HK$0.76
HK$0.03(9.09%)
Day’s Range― - ―
52-Week RangeHK$0.22 - HK$0.86
Previous CloseN/A
Volume864.00K
Average Volume (3M)617.89K
Market Cap
HK$575.66M
Enterprise ValueHK$205.61M
Total Cash (Recent Filing)HK$1.05M
Total Debt (Recent Filing)HK$6.50M
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Nov 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,387,138,200
10 Day Avg. Volume474,015
30 Day Avg. Volume617,889
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-14.98
Price to Sales (P/S)2.95
P/FCF Ratio-13.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated Healthcare Services ModelAn integrated healthcare model combining hospital investments, operations and health-tech creates multiple revenue channels (management fees, patient services, tech solutions). This diversification supports recurring income and cross-selling, enhancing resilience and scaling potential over the medium term.
Modest Reported LeverageLow absolute debt reduces near-term fixed financing obligations and gives management more options to restructure or seek new funding without a heavy interest burden. Modest leverage is a durable structural advantage if cash generation can be restored.
Stable Gross Margin ProfileRelatively steady gross margins indicate the company retains core service-level profitability despite revenue contraction. If top-line volumes recover, stable unit economics can translate to improved operating leverage and quicker restoration of profitability than if gross margins were eroding.
Bears Say
Multi-year Revenue DeclineSustained top-line contraction reduces the base over which fixed costs and overhead can be spread, undermining operating leverage. A shrinking revenue trajectory impairs scale-dependent hospital operations and makes recovery harder without clear demand drivers or new business wins.
Deep And Widening Operating LossesExtremely large operating losses signal the current cost structure is unsustainable at present scale. Persistent, wide losses erode retained capital, limit reinvestment, damage partner confidence, and increase the likelihood of operational cutbacks or restructuring to restore viability.
Negative Equity And Cash BurnNegative equity combined with recurring cash burn creates structural funding risk. It constrains access to new debt or equity on favorable terms, may force asset sales or dilutive financing, and threatens ongoing operations unless cash generation or external support improves.
China Health Group News
0673 FAQ
What was China Health Group Ltd’s price range in the past 12 months?
China Health Group Ltd lowest stock price was HK$0.22 and its highest was HK$0.86 in the past 12 months.
What is China Health Group Ltd’s market cap?
China Health Group Ltd’s market cap is HK$575.66M.
When is China Health Group Ltd’s upcoming earnings report date?
China Health Group Ltd’s upcoming earnings report date is Nov 27, 2026 which is in 144 days.
How were China Health Group Ltd’s earnings last quarter?
China Health Group Ltd released its earnings results on Jun 30, 2026. The company reported -HK$0.027 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.027.
Is China Health Group Ltd overvalued?
According to Wall Street analysts China Health Group Ltd’s price is currently Overvalued.
Does China Health Group Ltd pay dividends?
China Health Group Ltd does not currently pay dividends.
What is China Health Group Ltd’s EPS estimate?
China Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Ltd have?
China Health Group Ltd has 1,387,138,200 shares outstanding.
What happened to China Health Group Ltd’s price movement after its last earnings report?
China Health Group Ltd reported an EPS of -HK$0.027 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Ltd?
Currently, no hedge funds are holding shares in HK:0673
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Health Group Stock Smart Score
Company Description
China Health Group Ltd
Serving as an investment holding company, China Health Group Limited engages in a diverse range of operations. Within the People's Republic of China, its core business involves the supply and maintenance of medical equipment and disposables, coupled with the administration and operation of healthcare facilities. The company also extends its activities into commercial factoring and real estate investment. Previously operating under the name China HealthCare Holdings Limited, the company officially adopted "China Health Group Limited" in September 2015. Its principal office is located in Central, Hong Kong.
Technical Analysis
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―